Ming Zhou

机构：Sun Yat-sen University, Novartis (China), First Affiliated Hospital of Guangzhou Medical University, Guangzhou Blood Center, Guangzhou First People's Hospital, Zhongshan Hospital, Guangzhou Medical University Cancer Hospital, Zhongshan Ophthalmic Center, Sun Yat-sen University, South China University of Technology, Guangzhou Medical University · ORCID：0000-0003-2545-1134

发表论文 64 篇 · 总被引 1356 次 · h-index 20

代表论文

• Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study (2022 · Haematologica · 被引 71)
• Cytokine Receptor-Like Factor 3 Negatively Regulates Antiviral Immunity by Promoting the Degradation of TBK1 in Teleost Fish (2022 · Journal of Virology · 被引 36)
• Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro) (2022 · Frontiers in Immunology · 被引 34)
• Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial (2021 · 癌症：英文版 · 被引 26)
• IRF4b and IRF8 Negatively Regulate RLR-Mediated NF-κB Signaling by Targeting MITA for Degradation in Teleost Fish (2022 · Frontiers in Immunology · 被引 12)
• Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia (2024 · Blood Cancer Journal · 被引 10)